SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-24-013400
Filing Date
2024-04-08
Accepted
2024-04-05 21:59:24
Documents
82
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm   iXBRL 10-K 2418121
2 ex21-1.htm EX-21.1 2209
3 ex23-1.htm EX-23.1 3450
4 ex31-1.htm EX-31.1 16332
5 ex31-2.htm EX-31.2 16362
6 ex32-1.htm EX-32.1 9427
7 ex97-1.htm EX-97.1 38943
8 logo_001.jpg GRAPHIC 16181
  Complete submission text file 0001493152-24-013400.txt   10189105

Data Files

Seq Description Document Type Size
9 XBRL SCHEMA FILE qlgn-20231231.xsd EX-101.SCH 78038
10 XBRL CALCULATION FILE qlgn-20231231_cal.xml EX-101.CAL 86569
11 XBRL DEFINITION FILE qlgn-20231231_def.xml EX-101.DEF 336809
12 XBRL LABEL FILE qlgn-20231231_lab.xml EX-101.LAB 604449
13 XBRL PRESENTATION FILE qlgn-20231231_pre.xml EX-101.PRE 470839
85 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 1603052
Mailing Address 2042 CORTE DEL NOGAL CARLSBAD CALIFORNIA CA 92011
Business Address 2042 CORTE DEL NOGAL CARLSBAD CALIFORNIA CA 92011 (760) 918-9165
Qualigen Therapeutics, Inc. (Filer) CIK: 0001460702 (see all company filings)

IRS No.: 263474527 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37428 | Film No.: 24827976
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)